Yuemeng Wu

12 Wulumuqi Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization.

Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization.

Journal: Annals of medicine

Published: August 25, 2026

Snakebite-induced severe varicella: Exploring venom-related immune dysregulation in a case report.

Snakebite-induced severe varicella: Exploring venom-related immune dysregulation in a case report.

Journal: JAAD case reports

Published: February 13, 2026

Sympathetic nerve dysfunction exacerbates skin inflammation in atopic dermatitis.

Sympathetic nerve dysfunction exacerbates skin inflammation in atopic dermatitis.

Journal: The Journal of allergy and clinical immunology

Published: May 06, 2025

Opsin 3 in keratinocytes mediates the light-induced exaggeration of atopic dermatitis.

Opsin 3 in keratinocytes mediates the light-induced exaggeration of atopic dermatitis.

Journal: The Journal of allergy and clinical immunology

Published: December 18, 2024

Temporal and Topographical Heterogeneities in Clinical Manifestations of Atopic Dermatitis in China.

Temporal and Topographical Heterogeneities in Clinical Manifestations of Atopic Dermatitis in China.

Journal: Journal of clinical medicine

Published: November 13, 2024

Blood Transcriptome Signature as Indicator and Predictor for Efficacy of Abrocitinib in Treatment of Atopic Dermatitis.

Blood Transcriptome Signature as Indicator and Predictor for Efficacy of Abrocitinib in Treatment of Atopic Dermatitis.

Journal: The Journal of investigative dermatology

Published: October 22, 2024

Real-World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single-Center Prospective Study.

Real-World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single-Center Prospective Study.

Journal: Allergy

Published: September 03, 2024

The comparison of the efficacy and safety of fractional 1064 nm Nd:YAG picosecond laser and nonablative fractional 1565 nm laser in the treatment of enlarged pores: A prospective split-face study.

The comparison of the efficacy and safety of fractional 1064 nm Nd:YAG picosecond laser and nonablative fractional 1565 nm laser in the treatment of enlarged pores: A prospective split-face study.

Journal: Lasers in surgery and medicine

Published: July 28, 2022

Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab.

Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab.

Journal: The British journal of dermatology

Published: June 10, 2022

The Efficacy and Safety of Fractional 1064 nm Nd:YAG Picosecond Laser Combined With Intense Pulsed Light in the Treatment of Atrophic Acne Scar: A Split-Face Study.

The Efficacy and Safety of Fractional 1064 nm Nd:YAG Picosecond Laser Combined With Intense Pulsed Light in the Treatment of Atrophic Acne Scar: A Split-Face Study.

Journal: Lasers in surgery and medicine

Published: February 21, 2021

Identification and analysis of dysregulated lncRNA and associated ceRNA in the pathogenesis of keloid.

Identification and analysis of dysregulated lncRNA and associated ceRNA in the pathogenesis of keloid.

Journal: Annals of translational medicine

Published: April 21, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026